Paclitaxel releasing balloon - BIOTRONIK

Drug Profile

Paclitaxel releasing balloon - BIOTRONIK

Alternative Names: Drug-eluting balloon - BIOTRONIK; Pantera Lux Paclitaxel Releasing Balloon; Passeo-18 Lux; Passeo-18 Lux DCB

Latest Information Update: 06 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator BIOTRONIK
  • Class Antineoplastics; Diterpenes; Paclitaxels; Small molecules; Taxanes
  • Mechanism of Action Mitosis inhibitors; Proto-oncogene protein c-bcl-2 inhibitors; Tubulin polymerisation promoters
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Coronary artery restenosis
  • No development reported Ischaemic heart disorders; Peripheral arterial disorders

Most Recent Events

  • 06 Sep 2017 No development reported - Phase-II for Ischaemic heart disorders in Australia (Intracoronary)
  • 06 Sep 2017 No development reported - Phase-II for Peripheral arterial disorders in Belgium, Germany, Austria (Intra-arterial)
  • 22 Sep 2016 Biotronik Medical Device plans the phase III BIOLUX-P IV CHINA trial for Peripheral arterial disorders in China (Intra-arterial) (NCT02912715)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top